Brett Schrand

Research Assistant Professor

  • 157 Citations
20112019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Brett Schrand is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Immunity Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
tumors Physics & Astronomy
immunity Physics & Astronomy
antibodies Physics & Astronomy
Osteopontin Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2019

  • 157 Citations
  • 14 Article
5 Citations (Scopus)

Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target

Wei, J., Marisetty, A., Schrand, B., Gabrusiewicz, K., Hashimoto, Y., Ott, M., Grami, Z., Kong, L. Y., Ling, X., Caruso, H., Zhou, S., Wang, Y. A., Fuller, G. N., Huse, J., Gilboa, E., Kang, N., Huang, X., Verhaak, R., Li, S. & Heimberger, A. B., Jan 2 2019, In : Journal of Clinical Investigation. 129, 1, CI121266.

Research output: Contribution to journalArticle

Osteopontin
Glioblastoma
Macrophages
Glioma
Therapeutics

Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity

Garrido, G., Schrand, B., Rabasa, A., Levay, A., D’Eramo, F., Berezhnoy, A., Modi, S., Gefen, T., Marijt, K., Doorduijn, E., Dudeja, V., van Hall, T. & Gilboa, E., Dec 1 2019, In : Nature communications. 10, 1, 3773.

Research output: Contribution to journalArticle

Open Access
transporter
immunity
peptides
Tumors
Immunity

Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity

Schrand, B., Clark, E., Levay, A., Capote, A. R., Martinez, O., Brenneman, R., Castro, I. & Gilboa, E., Dec 1 2018, In : Nature Communications. 9, 1, 3348.

Research output: Contribution to journalArticle

Neoplasm Antibodies
Haptens
immunity
antibodies
Tumors
3 Citations (Scopus)

Potentiating tumor immunity using aptamer-targeted RNAi to render CD8+ T cells resistant to TGFβ inhibition

Puplampu-Dove, Y., Gefen, T., Rajagopalan, A., Muheramagic, D., Schrand, B. & Gilboa, E., Feb 14 2018, (Accepted/In press) In : OncoImmunology.

Research output: Contribution to journalArticle

RNA Interference
Immunity
T-Lymphocytes
Neoplasms
Small Interfering RNA
14 Citations (Scopus)

Aptamer-Targeted Attenuation of IL-2 Signaling in CD8+ T Cells Enhances Antitumor Immunity

Rajagopalan, A., Berezhnoy, A., Schrand, B., Puplampu-Dove, Y. & Gilboa, E., Jan 4 2017, In : Molecular Therapy. 25, 1, p. 54-61 8 p.

Research output: Contribution to journalArticle

Small Interfering RNA
Interleukin-2
Immunity
T-Lymphocytes
Vaccines